Home / NYKD.OL : OSL

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does NYKD.OL make money? Does NYKD.OL have pricing power? What's the Earnings Whisper? Will NYKD.OL profit more as the business scales? What is NYKD.OL's management track record? Is NYKD.OL's current price justified?

Nykode Therapeutics AS

NOK 3.00 +$0.65 (+27.33%)

OSL · 30 Oct 2026 15:25 UTC

Previous Close

NOK 3.02

Day Range

NOK 2.94NOK 3.08

Year Range

NOK 2.06NOK 5.20

Market Cap

1.18B

AVG Volume

1.68M

Trailing/Forward PE

-4.69/65.54

PEG ratio

-0.05

Dividend Yield

Next Earnings Date

2026-11-25

Primary Exchange

Oslo Stock Exchange

Revenue (USD) · A

NYKD.OL Revenue (USD) by year
Period	Revenue (USD)
2025	335K
2024	8.68M
2023	94.13M
2022	89.02M
2021	314.5M
2020	1.85B
2019	12.41M
2018	12.04M

Net Income (USD) · A

NYKD.OL Net Income (USD) by year
Period	Net Income (USD)
2025	-12.25M
2024	-38.82M
2023	-222.88M
2022	-428.57M
2021	-79.63M
2020	1.27B
2019	-120.32M
2018	-63.79M

Operating Income (USD) · A

NYKD.OL Operating Income (USD) by year
Period	Operating Income (USD)
2025	-28.59M
2024	-48.33M
2023	-313.26M
2022	-534.43M
2021	-90.73M
2020	1.51B
2019	-122.49M
2018	-65.84M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (USD) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 25 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Nykode Therapeutics AS

Earnings: NYKD.OL

Video analysis: NYKD.OL

News: NYKD.OL

Similar companies